Cardiex Ltd
ASX:CDX
Cardiex Ltd
ASX:CDX
Price:
0.054 AUD
1.89%
Market Closed
Updated:
May 6, 2024
Cardiex Ltd
Research & Development
|
Cardiex Ltd
Research & Development Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cardiex Ltd
ASX:CDX
|
Research & Development
-AU$3.2m
|
CAGR 3-Years
-98%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-9%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Research & Development
-AU$6.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-86%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Research & Development
-AU$236k
|
CAGR 3-Years
52%
|
CAGR 5-Years
39%
|
CAGR 10-Years
2%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Research & Development
-AU$3.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-57%
|
|
|
Cochlear Ltd
ASX:COH
|
Research & Development
-AU$269.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Research & Development
-AU$2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is Cardiex Ltd's Research & Development?
Research & Development
-3.2m
AUD
-3.2m
AUD
Based on the financial report for Dec 31, 2023, Cardiex Ltd's Research & Development amounts to -3.2m AUD.
What is Cardiex Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-9%
-9%
Over the last year, the Research & Development growth was 5%. The average annual Research & Development growth rates for Cardiex Ltd have been -98% over the past three years , -14% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
